ARS Pharma (SPRY): Bagan tingkat prakiraan

ARS Pharmaceuticals (SPRY) relies on exclusive patents for the first nasal form of adrenaline and significant R&D expenditures, operating under strict FDA oversight. This chart of current share prices on GURU.Markets shows a value of 24.44. ARS Pharmaceuticals is strengthening its authority among medical professionals by offering a safe alternative to injections, establishing the company as a sought-after defensive asset during any period of market recession.

SPRY: Target konsensus ARS Pharma 23.10.2026 - 23.10.2026

Rincian analitis perusahaan ARS Pharma (SPRY)

SPRY — sistem indikator bursa lan keuangan ARS Corp:

Bagan bursa ars-pharma.com|SPRY - Bagan rega target|Biji pasar ARS Pharma

Analisis umum perusahaan:SPRY ars-pharma.com

Barang unggulan ARS Corp

For ARS Pharmaceuticals (SPRY), the consolidated analyst target reflects the dynamics of the expected share value amid preparations for the Neffy launch. This indicator aggregates current expert valuations into a single daily trend, revealing the gap between the market price and fundamental value. The calculation is based on the weighted average of target prices from all relevant analysts. Stagnation of the line while quotes rise signals that the R&D pipeline drivers have been exhausted, allowing the investor to recognize the asset's overbought condition in a timely manner.

Pesaing ARS Pharmaceuticals

Target median analis haleon.com|Bagan rega target Kenvue KVUE|VRNA (Verona Pharma PLC) - Bagan tingkat prakiraan|MENS - Bagan rega target|Konsensus nilai wajar LGND (Ligand Corp)|AMRX (Amneal Pharmaceuticals) - Target konsensus|Rata-rata rega prakiraan perrigo.com (PRGO)|Bagan rega target Alvotech SA|Liquidia Corp - Bagan tingkat prakiraan|Prakiraan konsensus analis GLPG|ANIP (ANI Pharmaceuticals Corp) - Konsensus nilai wajar|Prakiraan konsensus analis MNKD (MannKind Corporation)|Prakiraan konsensus analis amphastar.com AMPH|PCRX - Bagan rega target|Konsensus nilai wajar TBPH (Theravance Biopharma Inc)|Aquestive Pharma (AQST) - Bagan rega target|Target konsensus scPharmaceuticals|TECX (Tectonic Therapeutic Inc.) - Prakiraan konsensus analis|Prakiraan konsensus analis tonixpharma.com|Target konsensus SXTC (China SXT Pharmaceuticals)|EPRX (eupraxiapharma.com) - Konsensus nilai wajar|Bagan rega target BioHarvest BHST|Invizyne (EXOZ) - Rata-rata rega prakiraan|ORMP: Target konsensus|Entera Bio Ltd. - Rega prakiraan analis|HYFT: Prakiraan konsensus analis|ABVC BioPharma Inc. - Konsensus nilai wajar|CPIX (Cumberland Pharma) - Prakiraan konsensus analis|Rata-rata rega prakiraan Quantum BioPharma Corp QNTM|Bagan rega target FibroGen, Inc. (FGEN)|TELO (telomirpharma.com) - Konsensus nilai wajar|Prakiraan konsensus analis RANI (Rani Therapeutics Holdings, Inc.)|Prakiraan konsensus analis Synergy CHC Corp. SNYR|RLYB - Bagan rega target|Konsensus nilai wajar LEXX (Lexaria Bioscience)|Pulmatrix, Inc. (PULM) - Bagan rega target|PTHL - Target median analis|Target konsensus APM|LYRA: Konsensus nilai wajar|Bagan rega target Impact BioMedical Inc (IBO)|TNFA: Bagan tingkat prakiraan|Prakiraan konsensus analis YCBD (cbdMD)|Konsensus nilai wajar PRFX|Auris Medical - Prakiraan konsensus analis|LIPO - Prakiraan konsensus analis|Optinose (OPTN) - Bagan rega target|Pieris Pharma - Konsensus nilai wajar|Bagan rega target Procaps Group S.A.|Target konsensus petrospharma.com (PTPI)|Prakiraan konsensus analis QLI|Prakiraan konsensus analis Acelyrin Inc. (SLRN)|Prakiraan konsensus analis TFFP (TFF Pharma)